Pathogenesis of respiratory viral and fungal coinfections
Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for develo** invasive fungal infections. Influenza virus is one of the most …
“at risk” groups for develo** invasive fungal infections. Influenza virus is one of the most …
Emerging fungal infections: new species, new names, and antifungal resistance
NP Wiederhold - Clinical chemistry, 2022 - academic.oup.com
Background Infections caused by fungi can be important causes of morbidity and mortality in
certain patient populations, including those who are highly immunocompromised or critically …
certain patient populations, including those who are highly immunocompromised or critically …
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …
Coronavirus disease 2019–associated mucormycosis: risk factors and mechanisms of disease
S Narayanan, JV Chua… - Clinical Infectious Diseases, 2022 - academic.oup.com
The severe surge of coronavirus disease 2019 (COVID-19) cases on the Indian
subcontinent in early 2021 was marked by an unusually high number of COVID-19 …
subcontinent in early 2021 was marked by an unusually high number of COVID-19 …
Aspergillus test profiles and mortality in critically ill COVID-19 patients
The literature regarding COVID-19-associated pulmonary aspergillosis (CAPA) has shown
conflicting observations, including survival of CAPA patients not receiving antifungal therapy …
conflicting observations, including survival of CAPA patients not receiving antifungal therapy …
Nosocomial fungal infections: epidemiology, infection control, and prevention
G Suleyman, GJ Alangaden - Infectious Disease Clinics, 2021 - id.theclinics.com
There has been an overall increase in fungal health care–associated infections (HAIs). The
increase is partly due to the increased population of immunocompromised patients at risk for …
increase is partly due to the increased population of immunocompromised patients at risk for …
An overview of using fungal DNA for the diagnosis of invasive mycoses
Introduction Fungal PCR has undergone considerable standardization and, together with
the availability of commercial assays, external quality assessment schemes, and extensive …
the availability of commercial assays, external quality assessment schemes, and extensive …
Mycobiome analyses of critically ill COVID-19 patients
ABSTRACT Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis
(CAPA) is a life-threatening complication in patients with severe COVID-19. Previously …
(CAPA) is a life-threatening complication in patients with severe COVID-19. Previously …
[HTML][HTML] Co-infections and superinfections complicating COVID-19 in cancer patients: a multicentre, international study
C Gudiol, X Durà-Miralles, J Aguilar-Company… - Journal of Infection, 2021 - Elsevier
Background We aimed to describe the epidemiology, risk factors, and clinical outcomes of
co-infections and superinfections in onco-hematological patients with COVID-19. Methods …
co-infections and superinfections in onco-hematological patients with COVID-19. Methods …
Prognostic impact of bronchoalveolar lavage fluid galactomannan and Aspergillus culture results on survival in COVID-19 intensive care unit patients: a post hoc …
DR Giacobbe, J Prattes, J Wauters… - Journal of clinical …, 2022 - journals.asm.org
Critically ill patients with coronavirus disease 2019 (COVID-19) may develop COVID-19-
associated pulmonary aspergillosis (CAPA), which impacts their chances of survival …
associated pulmonary aspergillosis (CAPA), which impacts their chances of survival …